Total Payments
$5,040
2024 Payments
$409.23
Companies
22
Transactions
61
Medicare Patients
6,762
Medicare Billing
$514,046
Payment Breakdown by Category
Food & Beverage$4,824 (95.7%)
Education$216.24 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,824 | 57 | 95.7% |
| Education | $216.24 | 4 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $553.24 | 5 | $0 (2024) |
| Novo Nordisk Inc | $505.39 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $453.69 | 6 | $0 (2019) |
| Amgen Inc. | $444.20 | 5 | $0 (2024) |
| Lilly USA, LLC | $375.01 | 4 | $0 (2024) |
| Allergan, Inc. | $361.97 | 3 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $332.96 | 3 | $0 (2023) |
| Amarin Pharma Inc. | $312.90 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $232.42 | 4 | $0 (2023) |
| PFIZER INC. | $218.16 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $409.23 | 6 | Lexicon Pharmaceuticals, Inc. ($125.00) |
| 2023 | $396.64 | 5 | Lilly USA, LLC ($125.00) |
| 2022 | $423.25 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
| 2021 | $351.61 | 5 | Astellas Pharma US Inc ($199.98) |
| 2020 | $254.42 | 3 | Allergan, Inc. ($238.13) |
| 2019 | $1,498 | 15 | Novo Nordisk Inc ($266.35) |
| 2018 | $664.24 | 10 | Novo Nordisk Inc ($222.75) |
| 2017 | $1,043 | 13 | AstraZeneca Pharmaceuticals LP ($225.00) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $117.70 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $110.62 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes Care | ||||||
| 03/20/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: DIABETES | ||||||
| 08/17/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Biological | ||||||
| 07/27/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $114.26 | General |
| Category: Central Nervous System | ||||||
| 06/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 05/19/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Urology | ||||||
| 08/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $98.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 03/02/2022 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $80.07 | General |
| 11/16/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 07/09/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes Care | ||||||
| 06/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $120.32 | General |
| Category: PRIMARY CARE | ||||||
| 06/22/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes Care | ||||||
| 01/12/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 07/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 03/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $118.77 | General |
| Category: NEUROSCIENCE | ||||||
| 01/07/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $75.34 | General |
| Category: Virology & Specialty Care | ||||||
| 11/12/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $92.31 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,346 | 1,943 | $233,710 | $115,278 |
| 2022 | 21 | 1,629 | 2,268 | $252,385 | $129,863 |
| 2021 | 22 | 1,581 | 2,161 | $235,290 | $132,165 |
| 2020 | 27 | 2,206 | 2,834 | $274,888 | $136,739 |
Total Patients
6,762
Total Services
9,206
Medicare Billing
$514,046
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 279 | 279 | $55,800 | $33,541 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 391 | $58,650 | $28,521 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 450 | $54,000 | $23,597 | 43.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 39 | 48 | $12,000 | $6,612 | 55.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 57 | 57 | $5,130 | $4,321 | 84.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $6,800 | $3,867 | 56.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 96 | $3,810 | $2,774 | 72.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 143 | 265 | $13,250 | $2,523 | 19.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,000 | $2,325 | 77.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 28 | $4,200 | $1,773 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 47 | $3,760 | $1,416 | 37.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 31 | 41 | $6,150 | $1,401 | 22.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 39 | 39 | $1,920 | $1,301 | 67.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 16 | 18 | $2,160 | $561.74 | 26.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 56 | $1,400 | $506.17 | 36.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $660.00 | $109.88 | 16.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 17 | 17 | $255.00 | $72.93 | 28.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 51 | $765.00 | $54.97 | 7.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 297 | 297 | $59,400 | $36,409 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 500 | $70,050 | $33,627 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 370 | $41,670 | $19,731 | 47.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 56 | 75 | $18,750 | $10,813 | 57.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 91 | 91 | $6,825 | $6,393 | 93.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 129 | 132 | $3,880 | $3,507 | 90.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $4,000 | $3,167 | 79.2% |
About Dr. Thopsie Jagannath, MD
Dr. Thopsie Jagannath, MD is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043257629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thopsie Jagannath, MD has received a total of $5,040 in payments from pharmaceutical and medical device companies, with $409.23 received in 2024. These payments were reported across 61 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,824).
As a Medicare-enrolled provider, Jagannath has provided services to 6,762 Medicare beneficiaries, totaling 9,206 services with total Medicare billing of $514,046. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 06/01/2006
- Last Updated 09/05/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043257629
Products in Payments
- Ozempic (Drug) $466.69
- XARELTO (Drug) $447.67
- JARDIANCE (Drug) $367.64
- Vascepa (Drug) $312.90
- Repatha (Biological) $304.63
- UBRELVY (Drug) $245.10
- MOUNJARO (Drug) $245.00
- VRAYLAR (Drug) $243.20
- BEVESPI AEROSPHERE (Drug) $225.00
- Inpefa (Drug) $125.00
- Kerendia (Drug) $125.00
- Aimovig (Biological) $124.98
- ELIQUIS (Drug) $123.46
- FASENRA (Drug) $122.50
- NURTEC ODT (Drug) $120.32
- ENTRESTO (Drug) $115.00
- Austedo XR (Drug) $114.26
- AIRSUPRA (Drug) $110.62
- AJOVY (Drug) $100.00
- TRELEGY ELLIPTA (Drug) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Internal Medicine $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518